We found that the mRNA expression of EZH2 was dose-dependently upregulated in the CTCL cell line H9 and the ALCL cell line Karpas 299 (Fig. 1D and Supplementary Fig. S2C). This evidence concerns the gene EZH2 and anaplastic large cell lymphoma.